510(k) Report

510(k) · Cleared

Cleared

OsteoProbe (OP-100)

K250216510(k) TraditionalCleared Sep 11, 2025230-day reviewClass II21 CFR 888.1600

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Active Life Scientific, Inc. · QGQ Bone Indentation Device

Cleared on Sep 11, 2025 as substantially equivalent to K221195 (Active Life Scientific, Inc., 2022) after a 230-day review. Its family tree reaches back 2 generations to 2021.

Decided
Sep 11, 2025
Review
230 days
Class
Class II
Product code
QGQ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN210013 (2021). No later device cites it as a predicate yet.

  1. Root · 2 generations backDEN210013 OsteoProbeActive Life Scientific, Inc. · 2021
  2. 1 generation backK221195 OsteoProbeActive Life Scientific, Inc. · 2022
  3. This deviceK250216 OsteoProbe (OP-100)Active Life Scientific, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN210013OsteoProbeActive Life Scientific, Inc.2021—
−1K221195OsteoProbeActive Life Scientific, Inc.2022—
0 (this device)K250216OsteoProbe (OP-100)Active Life Scientific, Inc.2025—
FIG. 1 — Lineage of K250216, 2021–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QGQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QGQ device

  1. #1 K221195 OsteoProbescore 6.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K221195OsteoProbe
Summary page 6
…erformance to the following predicate devices, which have been determined by FDA to be substantially equivalent to pre-amendment devices: Primary Predicate: OsteoProbe [K221195] Additional Predicate: N/A Performance Testing Summary: Performance testing on cadavers was completed to demonstrate correlation…
Active Life Scientific, Inc.2022—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 1 company; a new generation was cleared every 3.2 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All QGQ devices

QGQ Bone Indentation Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QGQ

1in 2025

2021: 12022: 12025: 1
2007high 1 (2021) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QGQ

Too few QGQ 510(k)s in any year since 2007 to give a median.

Recalls per year · QGQ

No recall names QGQ since 2007.

Adverse event reports per year · QGQ

No MAUDE report names QGQ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20221—00
20230—00
20240—00
20251—00
20260—0—

What is it indicated for?

The OsteoProbe is a measurement tool intended to assess bone tissue resistance to microindentation on the tibia of adults, reported as the Bone Material Strength Index (BMSi). In laboratory studies, BMSi measurements have been shown to correlate with biomechanical properties of bone, including whole-bone strength and fracture toughness. The clinical significance of laboratory-based biomechanical studies is unknown. The device is not intended to diagnose disease, predict fracture risk, or treat any clinical condition. Prescription use only, by or on the order of a physician.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K250216: OsteoProbe (OP-100).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K250216

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026